Research and Markets: Global Stem Cell Therapy Market 2014-2020: Treatment Mode, Therapeutic Applications, Regulatory Landscape & Pipeline Analysis
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/3fkh92/stem_cell_therapy) has announced the addition of the "Global Stem Cell Therapy Market 2014-2020: Treatment Mode, Therapeutic Applications, Regulatory Landscape & Pipeline Analysis" report to their offering.
“Global Stem Cell Therapy Market 2014-2020: Treatment Mode, Therapeutic Applications, Regulatory Landscape & Pipeline Analysis”
The global stem cell therapy market is estimated to grow at a lower CAGR in developed countries as compared to emerging countries such as China, India, and Korea in the forecast period (2015-2020). Factors such as increasing funding from various governments and private organizations focus on stem cell research by the growing industry, and rising global awareness about stem cell therapies through various organizations are propelling the growth of the stem cell therapy market. However, lack of required infrastructures, ethical issues related to embryonic stem cell, and the difficulties related with the preservation of stem cells are restraining the growth of this market.
In this report, the global stem cell therapy market has been segmented on the basis of mode of therapy (allogeneic and autologous stem cell therapy) and therapeutic applications (eye diseases, metabolic diseases, GIT diseases, musculoskeletal disorders, immune system diseases, CNS diseases, CVS diseases, wounds and injuries, and others). The allogeneic stem cell therapy market is expected to hold the largest share of the global stem cell therapy market by 2015. This large share can be attributed to the launch of the first-in-class stem cell therapy called prochymal (Osiris Therapeutics, Inc., U.S.), for the treatment of acute graft-versus-host disease (GVHD) in children. This allogeneic therapy was approved in New Zealand and Canada, in May 2012.
Additionally, allogeneic stem cell therapy market is expected to grow at a higher CAGR as compared to the autologous stem cell therapy. Factors such as wider therapeutic applications, easier production scale up, and larger number of ongoing clinical trials of allogeneic stem cell therapies compared to autologous stem cell therapies are stimulating its market growth.
Major players such as Mesoblast Ltd. (Australia), Aastrom Biosciences, Inc. (U.S.), Celgene Corporation (U.S.), and StemCells, Inc. (U.S.) are adopting several growth strategies such as new product approvals, partnerships/agreements/collaborations, joint ventures, mergers, and acquisitions in order to keep pace with the evolving industry trends.
Key Topics Covered:
2 Executive Summary
3 Market Dynamics
4 Pipeline Analysis
5 Investor Network
6 Global Stem Cell Therapy Market, By Mode Of Therapy
7 Global Stem Cell Therapy Market, By Therapeutic Applications
8 Regulatory Landscape
9 Global Stem Cell Therapy Market, By Geography
10 Competitive Landscape
11 Company Profiles
- Aastrom Biosciences Inc.
- Advanced Cell Technologies, Inc.
- Athersys Inc.
- Celgene Corporation
- Cellular Dynamics International
- Cytori Therapeutics, Inc.
- Fibrocell Science, Inc.
- Gamida Cell Ltd.
- Mesoblast Ltd.
- Pluristem Therapeutics Inc.
- StemCells Inc.
For more information visit http://www.researchandmarkets.com/research/3fkh92/stem_cell_therapy